IMS Receives Frost & Sullivan's 2025 North America Technology Innovation Leadership Recognition for Connected and Telematics Insurance
Recognized for driving innovation in connected insurance and telematics solutions, IMS demonstrates leadership in customer engagement, data-driven insights, and digital transformation SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost & Sullivan is...
InSkill Receives Frost and Sullivan's 2025 Global New Product Innovation Recognition for Its Industrial AI Copilot Platform
The company is honored for advancing industrial performance with GenAI copilots that improve equipment uptime, boost worker productivity, and streamline knowledge capture across industrial operations. SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost...
Frost & Sullivan: Health Recovery Solutions Receives the 2025 North American Customer Value Leadership Recognition for Excellence in Patient-Centered Care Delivery
Frost & Sullivan recognizes Health Recovery Solutions for delivering adaptable, outcomes-driven, technology-enabled longitudinal care models SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Health...
Health In Tech Announces Voluntary Extension of Lock-Up Period
STUART, Fla., Dec. 2, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced that its executive management team, vice presidents across functions, and Board of Directors...
PEPSICO® ANNOUNCES LANDMARK GLOBAL PARTNERSHIP WITH MERCEDES-AMG PETRONAS F1 TEAM FOR 2026
Gatorade®, Sting®, and Doritos® unite performance, energy, and flavor with the eight-time FIA World Constructors' Champions PURCHASE, N.Y., Dec. 2, 2025 /PRNewswire/ -- Today, PepsiCo announces a landmark global partnership with Mercedes-AMG...
Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy
SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. LONDON, Dec. 2, 2025 /PRNewswire/ -- Accord Healthcare today announced the launch of Osvyrti (denosumab), a biosimilar to Prolia®...
ZAGENO Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Life Sciences E-commerce Leadership
ZAGENO earns global recognition for driving innovation, operational efficiency, and transformative customer value across the life sciences e-commerce ecosystem. SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce...
Automic Group Announces Senior Executive Leadership Appointments to Drive Growth and Innovation Agenda
SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Automic Group, Australia's market leader in technology-driven investor administration and services, announces two senior executive appointments to drive further growth and accelerate the Group's strategy. Stacey...
Lynk Pharmaceuticals Announces FDA IND Approval of Its Allosteric TYK2 Inhibitor LNK01006
HANGZHOU, China and SHANGHAI and BOSTON, Dec. 2, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on developing innovative therapies...